United States · FDA National Drug Code directory
Budesonide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53746-778_6c4112fe-354a-472f-97ba-fa86d405b7f7
- Product NDC
- 53746-778
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Budesonide
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250522
- Source listing expiry
- 20261231
Source-listed ingredients
- BUDESONIDE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (53746-778-10) · 53746-778-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →